Illustration of Reddit’s mascot holding a golden upvote arrow with stock charts, dollar signs, and AI circuits in the background, symbolizing Reddit’s growth, buyback, and AI data monetization.

Reddit’s $1 Billion “Upvote”: The Front Page of the Internet Just Got a Massive Buyback

Reddit’s growth is on fire, margins are real, and a $1B buyback plus a $7.5M insider purchase just lit up the tape. Is RDDT the internet’s next compounding machine—or a premium, high-volatility AI data play? Let’s break it down, FUNanc1al style.

 

Read entire article

Editorial illustration of a satellite launching into orbit above a volatile stock chart, symbolizing York Space Systems’ ambitious technology and the market risks facing YSS investors.

York Space: Insiders Buy, But Give It Some… Space

York Space builds satellites fast and cheap—and insiders are buying. But with losses, high valuation, and heavy DoD dependence, YSS still needs time to prove it deserves a higher orbit.

Read entire article

Cartoon of a sleek insurance robot handing a briefcase labeled ‘Exzeo Group IPO’ to cheerful executives climbing a rising stock chart, with confetti and dollar signs floating around — symbolizing insider confidence and growth optimism.

Insiders Just Bought Shares of New Issue Exzeo Group; Should You Purchase XZO?

Exzeo Group (XZO) insiders bought right after the IPO. Profitable growth, strong margins, and a quirky Insurance-as-a-Service story worth watching.

 

Read entire article

Colorful illustration showing a cartoon delivery driver riding a rocket-powered scooter, surrounded by flying receipts, investor charts, burgers, and dollar bills raining down—symbolizing DoorDash’s explosive growth in both food and finance.

DoorDash Keeps Delivering — And Not Just Food

DoorDash isn’t just bringing food to your door—it’s bringing deals to Wall Street. From Deliveroo to SevenRooms, DASH is snapping up companies, stacking revenue, and gaining investor love. But can this delivery darling keep up the dash?

Read entire article

Cartoon of a CRISPR enzyme snipping DNA while hedge fund managers (ARKK & Baker Bros) cheer, and an insider waves a giant $1M buy ticket.

Intellia Therapeutics Update: Insider Buys, Institutional Muscle & Phase 3 Momentum

Intellia Therapeutics (NTLA) is up 20%, insiders are buying, ARKK and Baker Bros are holding or adding, and Phase 3 trials are moving faster than expected. Here’s why CRISPR medicine may be ready for prime time — or another plot twist.

Read entire article